Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in <i>MECOM</i>‐associated syndromes
Michell M. Lozano Chinga(Primary Children's Hospital), Taizo A. Nakano(Children's Hospital Colorado), Akiko Shimamura(Harvard University), R. Grant Rowe(Boston Children's Hospital), Kaylee Dollerschell(Children's Hospital Colorado), David A. Williams(Boston Children's Hospital), Alison A. Bertuch(Baylor College of Medicine), Emily S. Rao(Johns Hopkins Hospital), Joanne I. Hsu(Brigham and Women's Hospital), Vijay G. Sankaran(Broad Institute), Zeinab Afify(Primary Children's Hospital), Tami John(Baylor College of Medicine)
Cited by 18
Related Papers
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells
|Nature Biotechnology|2021|554
Highly efficient therapeutic gene editing of human hematopoietic stem cells
|Nature Medicine|2019|518
Mapping transcriptomic vector fields of single cells
|Cell|2022|475
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423